Low expression of E-cadherin (CDH1), ARID1A, FAT4, and KMT2C were associated with a poor prognosis in GC [25–28], while high expression of p53 or KMT2D was reported to be associated with a poor survival [29, 30]. Here, FAT4 is linked to gastric cancer.